Sutro Biopharma vs TippingPoint Biosciences
Sutro Biopharma vs TippingPoint Biosciences, compared side by side on 16 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: Sutro Biopharma is on 40/100 and TippingPoint Biosciences on 59/100.
Where each one leads
Sutro Biopharma
- agent readiness: 36/100 against 30/100
- funding raised: $296M against $14.5M
TippingPoint Biosciences
- our overall score: 59/100 against 40/100
- domain rating: 90/100 against 44/100
At a glance
| Measure | Sutro Biopharma | TippingPoint Biosciences |
|---|---|---|
| What it is | Clinical-stage biopharma developing precisely designed cancer therapeutics using a proprietary cell-free protein synthesis platform. | Developing novel therapeutics targeting dysfunctional DNA packaging for diseases like cancer. |
| Category | Biotech, Drug Discovery, Clinical Trials, Antibody-Drug Conjugates | Biotech, Drug Discovery, Antibody Therapeutics, Oncology |
| Sells toBusiness model | B2B | B2B |
| Offering | Platform | Services |
| Founded | 2003 | 2021 |
| Headquarters | South San Francisco, United States | Cambridge, USA |
| Status | Active | Inactive |
Size, funding and growth
| Measure | Sutro Biopharma | TippingPoint Biosciences |
|---|---|---|
| Employees | Not published | 7 |
| Total funding | $296M | $14.5M |
| Latest round | Public Offering | Seed |
| Valuation | Not published | $1.1B |
| LinkedIn followers | Not published | 1,122 |
StartupHub scores
Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.
| Measure | Sutro Biopharma | TippingPoint Biosciences |
|---|---|---|
| StartupHub scoreOur 0-100 rating | 40/100 | 59/100 |
| Traction | 40/100 | 45/100 |
| Team | 30/100 | 60/100 |
| Search visibility | 2/100 | 38/100 |
| Quality | 45/100 | 68/100 |
| Agent readinessHow well an AI agent can read and act on the site | F (36/100) | F (30/100) |
| Domain ratingLink authority, 0-100 | 44/100 | 90/100 |
Technology
Detected on each public site, so it reflects the marketing stack as well as the product.
| Measure | Sutro Biopharma | TippingPoint Biosciences |
|---|---|---|
| Hosting | AWS | Not detected |
| CDN | Not detected | Cloudflare |
| CMS | WordPress | Not detected |
| Frameworks | Jquery | Not detected |
| Analytics | Google Analytics 4, Segment | Not detected |
Sutro Biopharma vs TippingPoint Biosciences: common questions
Which is better, Sutro Biopharma or TippingPoint Biosciences?
On our 0-100 score TippingPoint Biosciences rates higher (59/100 against 40/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 16 data points above: read the rows that match what you are buying for.
How do Sutro Biopharma and TippingPoint Biosciences compare on the numbers?
Sutro Biopharma leads on agent readiness (36/100 against 30/100), funding raised ($296M against $14.5M). TippingPoint Biosciences leads on our overall score (59/100 against 40/100), domain rating (90/100 against 44/100).
Read the full Sutro Biopharma review and pricing or the TippingPoint Biosciences review and pricing. You can also browse other Sutro Biopharma alternatives we track.